Clinical Trials | October 09, 2023
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
Increased capability to produce medicines for challenging diseases including cancer
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Advances Amgen's mission to serve patients with rare disease medicines
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
Subscribe To Our Newsletter & Stay Updated
